亚洲社会药学 ›› 2019, Vol. 14 ›› Issue (3): 100-109.

• • 上一篇    下一篇

Group Purchasing Organizations (GPOs) in the U.S.: Development and Reform

Jin Jing1, 2, Xiong Jiamei1, 2, Yang Yue1, 2, Huang Zhe1, 2*   

  1. 1.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China; 2. International Center for Food and Drug Policy and Law Research, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2019-09-20 发布日期:2019-10-12

Group Purchasing Organizations (GPOs) in the U.S.: Development and Reform

Jin Jing1, 2, Xiong Jiamei1, 2, Yang Yue1, 2, Huang Zhe1, 2*   

  1. 1.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China; 2. International Center for Food and Drug Policy and Law Research, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2019-09-20 Published:2019-10-12
  • Contact: Huang Zhe, professor. Major research areas: knowledge management, E-commerce. Tel: 13998874590, E-mail: huangzhe2000@sina.com. E-mail:huangzhe2000@sina.com

摘要: Objective To study the characteristics, specific functions and policy improvement process of the Group Purchasing Organizations (GPOs) in the U.S. and to provide references for drug group purchasing practices in China. Methods Domestic and foreign relevant literatures, websites were reviewed or searched to analyze the functions and policy improvement process of the GPOs in the U.S. so as to provide references for drug group purchasing practices in China. Results and Conclusion As a third party in the U.S. GPOs has formed a relatively integrated business process and projects service system after long-term development. Supported by corresponding policies and industrial regulations, GPOs have made a great contribution to control the growth of medical and healthcare expenses and improve the efficiency of medical institutions, and its development experience can enlighten the practices in China.

关键词: group purchasing organization (GPO), drug purchase, the U.S.

Abstract: Objective To study the characteristics, specific functions and policy improvement process of the Group Purchasing Organizations (GPOs) in the U.S. and to provide references for drug group purchasing practices in China. Methods Domestic and foreign relevant literatures, websites were reviewed or searched to analyze the functions and policy improvement process of the GPOs in the U.S. so as to provide references for drug group purchasing practices in China. Results and Conclusion As a third party in the U.S. GPOs has formed a relatively integrated business process and projects service system after long-term development. Supported by corresponding policies and industrial regulations, GPOs have made a great contribution to control the growth of medical and healthcare expenses and improve the efficiency of medical institutions, and its development experience can enlighten the practices in China.

Key words: group purchasing organization (GPO), drug purchase, the U.S.